10x Genomics, Inc.
Stock Details
Is it expensive?
Trailing P/E Ratio
-62,34
Forward P/E Ratio
133,98
PEG Ratio
0,92
-37,66
Price-to-Sales (TTM)
4,44
3,58
6,24
Market Cap
2,79B
2,41B
Is it profitable?
Net Profit Margin (TTM)
-6,77%
Gross Profit Margin
68,09%
Diluted EPS (TTM)
-0,35
-5,78%
642,82M
Is it growing?
0,60%
0,61%
Is it risky?
2,17
10,59
4,46
84,36M
Who owns it?
107,97%
1,84%
19,56%
127,69M
115,30M
Does it pay?
0,00%
0,00%
--
--
How much cash?
523,41M
136,05M
148,39M
4,10
- Price
- 23,02
- Percent Change
- +1,20 (5,50%)
- Previous Close
- 21,82
- Open
- 23,38
- Low
- 22,45
- High
- 23,62
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$23,02
From 52W Low
+231.70%
From 52W High
-2.54%
Today
+5.50%
1Y Change
+165.51%
6M
$11,71
3M
$20,46
1M
$20,91
Today
$23,02
From 52W Low
+231.70%
From 52W High
-2.54%
Today
+5.50%
1Y Change
+165.51%
6M
$11,71
3M
$20,46
1M
$20,91
Today
$23,02
Expensive
within its 1-year price range
$23,02
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+10.1%
3M
+12.5%
6M
+96.6%
1Y
+165.5%
Rate of Change (ROC)
Weakening
Price is rising, but slower than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- 10x Genomics, Inc.
- Founded
- Jan 1, 2012
- Founders
- Dr. Serge Saxonov Ph.D., Ben Hindson, Kevin Ness
- CEO
- Serge Saxonov
- Employees
- 1306
- Fiscal Year End
- Dec 31, 2025
- Address
6230 Stoneridge Mall Road
Pleasanton
California
94588
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.10xgenomics.com
Indicators
Operating Cash Flow
136,05M
Net Income
-43,54M
Warning Sign
-3.12
Reported profit and cash flow are moving in opposite directions. This is a major red flag associated with aggressive accounting, financial stress, or early-stage distress.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
136,05M
Net Income
-43,54M
Warning Sign
-3.12
Reported profit and cash flow are moving in opposite directions. This is a major red flag associated with aggressive accounting, financial stress, or early-stage distress.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
-62,34
Forward P/E Ratio
133,98
PEG Ratio
0,92
-37,66
Price-to-Sales (TTM)
4,44
3,58
6,24
Market Cap
2,79B
2,41B
Is it profitable?
Net Profit Margin (TTM)
-6,77%
Gross Profit Margin
68,09%
Diluted EPS (TTM)
-0,35
-5,78%
642,82M
Is it growing?
0,60%
0,61%
Is it risky?
2,17
10,59
4,46
84,36M
Who owns it?
107,97%
1,84%
19,56%
127,69M
115,30M
Does it pay?
0,00%
0,00%
--
--
How much cash?
523,41M
136,05M
148,39M
4,10
- Price
- 23,02
- Percent Change
- +1,20 (5,50%)
- Previous Close
- 21,82
- Open
- 23,38
- Low
- 22,45
- High
- 23,62
52-Week Range Position (52WRP)
Expensive
Expensive
within its 1-year price range
$23,02
From 52W Low
+231.70%
From 52W High
-2.54%
Today
+5.50%
1Y Change
+165.51%
6M
$11,71
3M
$20,46
1M
$20,91
Today
$23,02
From 52W Low
+231.70%
From 52W High
-2.54%
Today
+5.50%
1Y Change
+165.51%
6M
$11,71
3M
$20,46
1M
$20,91
Today
$23,02
Expensive
within its 1-year price range
$23,02
Multi-Timeframe Analysis (MTA)
Strong Uptrend
All four timeframes point up. This is the strongest bullish signal. Fully-aligned multi-period trends carry the highest continuation probability. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+10.1%
3M
+12.5%
6M
+96.6%
1Y
+165.5%
Rate of Change (ROC)
Weakening
Price is rising, but slower than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- 10x Genomics, Inc.
- Founded
- Jan 1, 2012
- Founders
- Dr. Serge Saxonov Ph.D., Ben Hindson, Kevin Ness
- CEO
- Serge Saxonov
- Employees
- 1306
- Fiscal Year End
- Dec 31, 2025
- Address
6230 Stoneridge Mall Road
Pleasanton
California
94588
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.10xgenomics.com